NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Leisha A Emens
University of Pittsburgh - Pittsburgh / United States
Others
AD Scientific Index ID: 4702874
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Leisha A Emens's MOST POPULAR ARTICLES
1-)
Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancerP Schmid, S Adams, HS Rugo, A Schneeweiss, CH Barrios, H Iwata, ...New England Journal of Medicine 379 (22), 2108-2121, 201828612018
2-)
Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results …P Schmid, HS Rugo, S Adams, A Schneeweiss, CH Barrios, H Iwata, ...The Lancet Oncology 21 (1), 44-59, 20207052020
3-)
The interplay of immunotherapy and chemotherapy: harnessing potential synergiesLA Emens, G MiddletonCancer immunology research 3 (5), 436-443, 20155732015
4-)
Breast cancer immunotherapy: facts and hopesLA EmensClinical cancer research 24 (3), 511-520, 20187782018
5-)
Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor studyLY Dirix, I Takacs, G Jerusalem, P Nikolinakos, HT Arkenau, ...Breast cancer research and treatment 167, 671-686, 20187542018
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept